procainamide has been researched along with Coronary Disease in 115 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with inducible, sustained ventricular tachycardia (VT) were prospectively evaluated to determine whether the response to intravenous procainamide administration, as assessed by programmed ventricular stimulation, predicted the response to oral procainamide and oral quinidine treatment." | 9.05 | Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment. ( Gang, ES; Mandel, WJ; Oseran, DS; Peter, T; Rosenthal, ME, 1985) |
| "To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of tachycardia, 15 patients with inducible, sustained ventricular tachycardia in the setting of chronic coronary artery disease were studied." | 7.68 | Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. ( Callans, DJ; Marchlinski, FE, 1992) |
| "We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient." | 7.68 | Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT, 1990) |
| "The efficacy of combination therapy using a type IA agent (quinidine or procainamide) and a type IB agent (mexiletine) in suppressing inducible sustained ventricular tachyarrhythmias was studied in 23 patients undergoing serial drug testing with programmed stimulation." | 7.67 | Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. ( Greenspan, AM; Horowitz, LN; Rae, AP; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| "We compared the effects of verapamil to high dose procainamide on the rate of inducible and spontaneously occurring ventricular tachycardia (VT) in 10 patients." | 7.67 | Verapamil in ventricular tachycardia. ( Gotsman, MS; Hasin, Y; Kriwisky, M, 1984) |
| "The effects of lidocaine, tocainide and mexiletine were examined in 17 patients with coronary artery disease and chronic, recurrent, sustained ventricular tachycardia (VT) or ventricular fibrillation and inducible VT." | 7.67 | Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. ( Easley, AR; Mann, DE; Reiter, MJ, 1987) |
| "Antiarrhythmic properties of N-acetylprocainamide (NAPA), an active metabolite of procainamide, were studied in 12 patients with coronary artery disease who presented with cardiac arrest or documented sustained ventricular tachycardia (VT)." | 7.67 | Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. ( Flowers, D; Keefe, D; Miura, DS; Somberg, JC; Torres, V; Williams, S; Wynn, J, 1985) |
| "The influence of the vagolytic effect of procainamide on the early ventricular arrhythmias induced by left anterior descending coronary (LAD) occlusion was studied in chloraloseanaesthetised cats." | 7.66 | Exacerbation of coronary occlusion induced ventricular arrhythmias by the vagolytic effect of procainamide. ( Corr, PB; Gillis, RA; Helke, CJ, 1978) |
| "We compared the relationship between plasma levels of procainamide and suppression or prevention of various forms of ventricular arrhythmias in 18 patients, six of whom had premature ventricular complexes (PVCs) during acute myocardial infarction (AMI), six of whom had PVCs in the setting of stable chronic ischemic heart disease (CIHD), and six of whom had recurrent symptomatic ventricular tachycardia (VT) with chronic PVCs between episodes of VT." | 7.66 | Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia. ( Castellanos, A; Conde, CA; Cooper, D; Kessler, KM; Kiem, I; Myerburg, RJ; Pefkaros, KC, 1981) |
| "Fifteen consecutive patients with coronary artery disease had rapid (158 to 272 beats/min) and sustained ventricular tachycardia induced by the extrastimulus technique, and received procainamide infusion." | 7.66 | Modification of ventricular tachycardia by procainamide in patients with coronary artery disease. ( Engel, TR; Luck, JC; Meister, SG, 1980) |
| "The effects of a single intravenous infusion of 750 mg of procainamide was studied in 12 patients with symptomatic chronic recurrent ventricular tachycardia in whom arrhythmias could reproducibly be initiated and terminated by programmed electrical stimulation of the heart." | 7.66 | Procainamide in the induction and perpetuation of ventricular tachycardia in man. ( El-Sherif, N; Gomes, JA; Kang, PS, 1982) |
| "Lidocaine pretreatment (10 mg/kg i." | 5.26 | Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. ( Bergey, JL; McCallum, JD; Nocella, K, 1982) |
| "Eleven patients with chronic ventricular arrhythmias took part in a study of N-acetylprocainamide (NAPA), the major metabolite of procainamide, in order to characterize further NAPA's clinical pharmacology and antiarrhythmic action." | 5.05 | Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide. ( Jaillon, P; Kates, RE; Peters, F; Winkle, RA, 1981) |
| "Twenty patients with inducible, sustained ventricular tachycardia (VT) were prospectively evaluated to determine whether the response to intravenous procainamide administration, as assessed by programmed ventricular stimulation, predicted the response to oral procainamide and oral quinidine treatment." | 5.05 | Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment. ( Gang, ES; Mandel, WJ; Oseran, DS; Peter, T; Rosenthal, ME, 1985) |
| "To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of tachycardia, 15 patients with inducible, sustained ventricular tachycardia in the setting of chronic coronary artery disease were studied." | 3.68 | Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. ( Callans, DJ; Marchlinski, FE, 1992) |
| "We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient." | 3.68 | Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT, 1990) |
| "We compared the effects of verapamil to high dose procainamide on the rate of inducible and spontaneously occurring ventricular tachycardia (VT) in 10 patients." | 3.67 | Verapamil in ventricular tachycardia. ( Gotsman, MS; Hasin, Y; Kriwisky, M, 1984) |
| "Antiarrhythmic properties of N-acetylprocainamide (NAPA), an active metabolite of procainamide, were studied in 12 patients with coronary artery disease who presented with cardiac arrest or documented sustained ventricular tachycardia (VT)." | 3.67 | Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. ( Flowers, D; Keefe, D; Miura, DS; Somberg, JC; Torres, V; Williams, S; Wynn, J, 1985) |
| "The effects of lidocaine, tocainide and mexiletine were examined in 17 patients with coronary artery disease and chronic, recurrent, sustained ventricular tachycardia (VT) or ventricular fibrillation and inducible VT." | 3.67 | Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. ( Easley, AR; Mann, DE; Reiter, MJ, 1987) |
| "Though the efficacies of procainamide and disopyramide in treating arrhythmias are well established, their precise mechanisms of antiarrhythmic action remain unclear." | 3.67 | Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart. ( Kobayashi, A; Watanabe, H; Yamazaki, N, 1988) |
| "The efficacy of combination therapy using a type IA agent (quinidine or procainamide) and a type IB agent (mexiletine) in suppressing inducible sustained ventricular tachyarrhythmias was studied in 23 patients undergoing serial drug testing with programmed stimulation." | 3.67 | Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. ( Greenspan, AM; Horowitz, LN; Rae, AP; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| "The effects of a single intravenous infusion of 750 mg of procainamide was studied in 12 patients with symptomatic chronic recurrent ventricular tachycardia in whom arrhythmias could reproducibly be initiated and terminated by programmed electrical stimulation of the heart." | 3.66 | Procainamide in the induction and perpetuation of ventricular tachycardia in man. ( El-Sherif, N; Gomes, JA; Kang, PS, 1982) |
| "For the purpose to evaluate the effects of lidocaine on the ventricular arrhythmias occurring as complications of acute myocardial ischemia or infarction, the electrophysiological actions of lidocaine were estimated, as compared with those of procainamide, on the right ventricular papillary muscle of the rabbit heart superfused with hypoxic, hyperkalemic and/or acidic Krebs-Ringer solution." | 3.66 | The electrophysiological actions of lidocaine on ischemic ventricular muscle as compared with procainamide. ( Furuta, T; Toyama, J, 1983) |
| "The influence of the vagolytic effect of procainamide on the early ventricular arrhythmias induced by left anterior descending coronary (LAD) occlusion was studied in chloraloseanaesthetised cats." | 3.66 | Exacerbation of coronary occlusion induced ventricular arrhythmias by the vagolytic effect of procainamide. ( Corr, PB; Gillis, RA; Helke, CJ, 1978) |
| "Fifteen consecutive patients with coronary artery disease had rapid (158 to 272 beats/min) and sustained ventricular tachycardia induced by the extrastimulus technique, and received procainamide infusion." | 3.66 | Modification of ventricular tachycardia by procainamide in patients with coronary artery disease. ( Engel, TR; Luck, JC; Meister, SG, 1980) |
| "We compared the relationship between plasma levels of procainamide and suppression or prevention of various forms of ventricular arrhythmias in 18 patients, six of whom had premature ventricular complexes (PVCs) during acute myocardial infarction (AMI), six of whom had PVCs in the setting of stable chronic ischemic heart disease (CIHD), and six of whom had recurrent symptomatic ventricular tachycardia (VT) with chronic PVCs between episodes of VT." | 3.66 | Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia. ( Castellanos, A; Conde, CA; Cooper, D; Kessler, KM; Kiem, I; Myerburg, RJ; Pefkaros, KC, 1981) |
| "The author describes the notions that led to initiation of controlled trials of long-term medication with antiarrhythmic drugs following myocardial infarction, and reviews reports of controlled trials with diphenylhydantoin, alprenolol, and procaine amide." | 3.65 | Arrhythmia prophylaxis: Long-term suppressive medication. ( Lovell, RR, 1975) |
| " Procainamide was received for 4 days; the dosage was adjusted for body weight." | 2.68 | Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. ( Buckley, MJ; DeSanctis, RW; Gold, MR; O'Gara, PT, 1996) |
| "After two hours extrasystoles decreased to 63% of the initial level." | 2.64 | [Effect of prajmalium bitartrate and procaine amide on ventricular extrasystoles (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Müller, E, 1976) |
| "Digoxin therapy was initiated in 101 patients." | 1.28 | Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery disease. ( Acheson, A; Goldstein, S; Landis, JR; Leighton, R; Moosvi, AR; Ritter, G; VanderBrug Medendorp, S; Vasu, CM; Wolfe, RA, 1990) |
| "Despite widespread marketing of a sustained release preparation of procainamide hydrochloride (PROCAN-SR, Parke-Davis), published literature demonstrating its efficacy in maintaining uniform serum drug levels over a 6-hour dosing interval is derived from only normal healthy volunteers." | 1.27 | Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation. ( Mirando, T; Zema, MJ, 1983) |
| "Procainamide is a potent inducer of autoantibodies." | 1.27 | Effects of long-term procainamide therapy on immunoglobulin synthesis. ( Yu, CL; Ziff, M, 1985) |
| "Symptomatic ventricular arrhythmias require treatment, whereas benign simple ventricular ectopy does not; however, the treatment of asymptomatic high-grade ventricular ectopy remains controversial." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
| "In 33 patients, premature beats were also introduced 330 msec beyond the RV refractory period to compare effects of long and short compensatory pauses on frequency of postextrasystolic T wave alterations." | 1.26 | Evaluation of postextrasystolic T wave alterations in identification of patients with coronary artery disease or left ventricular dysfunction. ( Dehmer, GJ; Firth, BG; Hillis, LD; Leachman, DR; Markham, RV; Winniford, MD, 1981) |
| "Lidocaine pretreatment (10 mg/kg i." | 1.26 | Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. ( Bergey, JL; McCallum, JD; Nocella, K, 1982) |
| "Nine of these had ventricular arrhythmia refractory to drugs." | 1.25 | Atrial pacing to control heart rate and rhythm in acute cardiac conditions. ( Friesen, WG, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 104 (90.43) | 18.7374 |
| 1990's | 11 (9.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CALVERT, R | 1 |
| SMITH, E | 1 |
| DAVIS, HC | 1 |
| MORSE, IS | 1 |
| DICK, MM | 1 |
| SEMPLE, T | 1 |
| DALL, JL | 1 |
| LANCASTER, WM | 1 |
| WANG, I | 1 |
| GRIGOR, K | 1 |
| PEEL, AA | 1 |
| BJERKELUND, C | 1 |
| JAKOBSEN, E | 1 |
| ZION, MM | 1 |
| BRADLOW, BA | 1 |
| KELLEY, RT | 1 |
| MACKENZIE, GJ | 1 |
| PASCUAL, S | 1 |
| REYNOLDS, EW | 1 |
| BAIRD, WM | 1 |
| CLIFFORD, ME | 1 |
| DESANCTIS, RW | 3 |
| Freeman, GS | 1 |
| Thurmann, M | 1 |
| Vlay, SC | 1 |
| Reid, PR | 1 |
| Kates, RE | 2 |
| Jaillon, P | 2 |
| Rubenson, DS | 1 |
| Winkle, RA | 5 |
| Peters, F | 1 |
| Leachman, DR | 1 |
| Dehmer, GJ | 1 |
| Firth, BG | 1 |
| Markham, RV | 1 |
| Winniford, MD | 1 |
| Hillis, LD | 1 |
| Kluger, J | 1 |
| Horner, H | 1 |
| Reidenberg, MM | 1 |
| Myerburg, RJ | 4 |
| Zaman, L | 1 |
| Kessler, KM | 2 |
| Castellanos, A | 3 |
| Kang, PS | 1 |
| Gomes, JA | 1 |
| El-Sherif, N | 2 |
| Zema, MJ | 1 |
| Mirando, T | 1 |
| Markov, KV | 1 |
| Sapozhnikov, AA | 1 |
| Mayer, NM | 1 |
| Hasin, Y | 1 |
| Kriwisky, M | 1 |
| Gotsman, MS | 1 |
| Sung, RJ | 1 |
| Shen, EN | 1 |
| Morady, F | 1 |
| Scheinman, MM | 1 |
| Hess, D | 1 |
| Botvinick, EH | 1 |
| Toyama, J | 1 |
| Furuta, T | 1 |
| Zarazaga, G | 1 |
| Salazar, J | 1 |
| Oliván, MJ | 1 |
| García, MD | 1 |
| Felipe, J | 1 |
| Ferro, G | 1 |
| Chiariello, M | 1 |
| Tari, MG | 1 |
| Vigorito, C | 1 |
| Ungaro, B | 1 |
| Condorelli, M | 1 |
| van Pham, C | 1 |
| Noguchi, J | 1 |
| Quismorio, FP | 1 |
| Haywood, LJ | 1 |
| Citone, C | 1 |
| Di Marcotullio, G | 1 |
| Polizzi, C | 1 |
| Uguccioni, M | 1 |
| Carelli, M | 1 |
| Masini, V | 1 |
| Epstein, K | 1 |
| Gaide, MS | 1 |
| Wong, SS | 1 |
| Gelband, H | 1 |
| Cameron, JS | 2 |
| Bassett, AL | 2 |
| Bergey, JL | 1 |
| Nocella, K | 1 |
| McCallum, JD | 1 |
| Kiem, I | 1 |
| Pefkaros, KC | 1 |
| Conde, CA | 1 |
| Cooper, D | 1 |
| Lewis, RP | 1 |
| Boudoulas, H | 1 |
| Leier, CV | 1 |
| Unverferth, DV | 1 |
| Weissler, AM | 1 |
| Ettinger, PO | 1 |
| Moore, RJ | 1 |
| Calabro, J | 1 |
| Oldewurtel, HA | 1 |
| Regan, TJ | 2 |
| Wenger, TL | 2 |
| Browning, DJ | 1 |
| Masterton, CE | 2 |
| Abou-Donia, MB | 2 |
| Harrell, FE | 1 |
| Bache, RJ | 2 |
| Strauss, HC | 2 |
| Engel, TR | 1 |
| Meister, SG | 1 |
| Luck, JC | 1 |
| Klein, H | 1 |
| Trappe, HJ | 1 |
| Fieguth, HG | 1 |
| Nisam, S | 1 |
| Aizawa, Y | 1 |
| Naitoh, N | 1 |
| Washizuka, T | 1 |
| Kitazawa, H | 1 |
| Takahashi, K | 1 |
| Kodama, I | 1 |
| Shibata, A | 1 |
| Pires, LA | 1 |
| Wagshal, AB | 1 |
| Greene, TO | 1 |
| Mittleman, RS | 1 |
| Huang, SK | 1 |
| Gillis, AM | 1 |
| Duff, HJ | 1 |
| Mitchell, LB | 1 |
| Wyse, DG | 1 |
| Gold, MR | 1 |
| O'Gara, PT | 1 |
| Buckley, MJ | 1 |
| Matiouchine, GV | 1 |
| Shulman, VA | 1 |
| Balog, AI | 1 |
| Bezruk, AP | 1 |
| Golovenkin, SE | 1 |
| Laurencet, FL | 1 |
| Corr, PB | 2 |
| Sobel, BE | 1 |
| Lovell, RR | 1 |
| Bussmann, WD | 1 |
| Müller, E | 1 |
| Kaltenbach, M | 1 |
| D'Amato, PH | 1 |
| Taylor, JB | 1 |
| Rios, JC | 1 |
| Breithardt, G | 1 |
| Seipel, L | 1 |
| Loogen, F | 1 |
| Reynolds, RD | 1 |
| Kamath, BL | 1 |
| Ruffy, R | 1 |
| Zipes, DP | 1 |
| Smitherman, TC | 1 |
| Gottlich, CM | 1 |
| Narahara, KA | 1 |
| Osborn, RC | 1 |
| Platt, M | 1 |
| Rude, RE | 1 |
| Lipscomb, K | 1 |
| Derrington, DC | 1 |
| Schroeder, JS | 1 |
| Lee, KL | 1 |
| Helke, CJ | 1 |
| Gillis, RA | 1 |
| Nathan, MP | 1 |
| Haider, B | 1 |
| Ahmed, SS | 1 |
| Alderman, EL | 1 |
| Fitzgerald, JW | 1 |
| Harrison, DC | 1 |
| Klein, MD | 1 |
| Levites, R | 1 |
| Haft, JI | 1 |
| Calderon, J | 1 |
| Chi, LG | 1 |
| Mu, DX | 1 |
| Driscoll, EM | 1 |
| Lucchesi, BR | 1 |
| Buxton, AE | 3 |
| Rosenthal, ME | 2 |
| Marchlinski, FE | 4 |
| Miller, JM | 1 |
| Flores, B | 1 |
| Josephson, ME | 4 |
| Callans, DJ | 1 |
| Moosvi, AR | 1 |
| Goldstein, S | 1 |
| VanderBrug Medendorp, S | 1 |
| Landis, JR | 1 |
| Wolfe, RA | 1 |
| Leighton, R | 1 |
| Ritter, G | 1 |
| Vasu, CM | 1 |
| Acheson, A | 1 |
| Vaitkus, PT | 1 |
| Wynn, J | 1 |
| Miura, DS | 1 |
| Torres, V | 1 |
| Flowers, D | 1 |
| Keefe, D | 1 |
| Williams, S | 1 |
| Somberg, JC | 1 |
| Reiter, MJ | 1 |
| Easley, AR | 1 |
| Mann, DE | 1 |
| Yu, CL | 1 |
| Ziff, M | 1 |
| Kobayashi, A | 1 |
| Watanabe, H | 1 |
| Yamazaki, N | 1 |
| Liem, LB | 1 |
| Mason, DM | 1 |
| Swerdlow, CD | 1 |
| Platia, EV | 1 |
| Weisfeldt, ML | 1 |
| Franz, MR | 1 |
| Schmitt, C | 1 |
| Kadish, AH | 1 |
| Balke, WC | 1 |
| Turk, K | 1 |
| Gallagher, JD | 1 |
| Fernandez, J | 1 |
| Maranhao, V | 1 |
| Gessman, LJ | 1 |
| Siegel, RJ | 1 |
| Fealy, M | 1 |
| Edwalds, G | 1 |
| Karagueuzian, H | 1 |
| Fishbein, MC | 1 |
| Gardner, MJ | 1 |
| McCarthy, DM | 1 |
| Oseran, DS | 1 |
| Gang, ES | 1 |
| Mandel, WJ | 1 |
| Peter, T | 1 |
| Waldecker, B | 1 |
| Brugada, P | 1 |
| Zehender, M | 1 |
| Stevenson, W | 1 |
| Den Dulk, K | 1 |
| Wellens, HJ | 1 |
| Kimura, S | 1 |
| Saoudi, NC | 1 |
| Kozlovskis, PL | 1 |
| Greenspan, AM | 1 |
| Spielman, SR | 1 |
| Webb, CR | 1 |
| Sokoloff, NM | 1 |
| Rae, AP | 1 |
| Horowitz, LN | 1 |
| Klajman, A | 1 |
| Camin-Belsky, N | 1 |
| Kimchi, A | 1 |
| Ben-Efraim, S | 1 |
| Konttinen, YP | 1 |
| Tuominen, L | 1 |
| Surawicz, B | 2 |
| Tobin, JR | 1 |
| Scanlon, PJ | 1 |
| Moran, JF | 1 |
| Talano, JV | 1 |
| Johnson, S | 1 |
| Gunnar, RM | 1 |
| Chung, EK | 1 |
| Helfant, RH | 1 |
| Seuffert, GW | 1 |
| Patton, RD | 1 |
| Stein, E | 1 |
| Damato, AN | 1 |
| Molina, J | 1 |
| Dubois, EL | 1 |
| Bilitch, M | 1 |
| Bland, SL | 1 |
| Friou, GJ | 1 |
| Giardina, EG | 2 |
| Bigger, JT | 2 |
| Saheta, NP | 1 |
| Valère, PE | 1 |
| Guérot, C | 1 |
| Lancelin, B | 1 |
| Tricot, R | 1 |
| Rydén, L | 1 |
| Hjalmarson, A | 1 |
| Wasir, H | 1 |
| Werkö, L | 1 |
| Hope, RR | 1 |
| Williams, DO | 1 |
| Lazzara, R | 1 |
| Scherlag, BJ | 1 |
| Koch-Weser, J | 1 |
| England, RA | 1 |
| Kunstadt, D | 1 |
| Punja, M | 1 |
| Cagin, N | 1 |
| Fernandez, P | 1 |
| Levitt, B | 1 |
| Yuceoglu, YZ | 1 |
| Yoon, MS | 2 |
| Han, J | 2 |
| Goel, BG | 2 |
| Creamer, P | 1 |
| Rogers, R | 1 |
| Nohara, Y | 1 |
| Blount, AW | 1 |
| Kemp, VE | 1 |
| Krauss, KR | 1 |
| Hutter, AM | 1 |
| Sommers, HM | 1 |
| Jennings, RB | 1 |
| Douglas, AH | 1 |
| Parkinson, PI | 1 |
| Wattie, WJ | 1 |
| Kirk, GM | 1 |
| Edhag, O | 1 |
| Mitsui, T | 1 |
| Mckenna, G | 1 |
| Engle, RP | 1 |
| Brooks, H | 1 |
| Dalen, J | 1 |
| Dhurandhar, RW | 1 |
| Teasdale, SJ | 1 |
| Mahon, WA | 1 |
| Friesen, WG | 1 |
| Luria, MH | 1 |
| Radzivil, VF | 1 |
| Fedyshin, PS | 1 |
| Furkalo, NK | 1 |
| Korkushko, OV | 1 |
| Warner, HR | 1 |
| Budkin, A | 1 |
| Küchler, I | 1 |
| Dyk, T | 1 |
| Grezlikowski, J | 1 |
| Tymieniecka, J | 1 |
| Aberg, H | 1 |
| Hey, EB | 1 |
| Makous, N | 1 |
| Vander Veer, JB | 1 |
| Popova, NK | 1 |
| Ivashkevich, EI | 1 |
| Steward, DJ | 1 |
| Baker, CB | 1 |
| Finlayson, DC | 1 |
8 reviews available for procainamide and Coronary Disease
| Article | Year |
|---|---|
[Frequency, prognosis, and treatment of cardiac arrhythmias in coronary heart disease--a review (author's transl)].
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; Germany, West; Humans; Phenyto | 1978 |
Ventricular fibrillation.
Topics: Aconitum; Action Potentials; Animals; Antipsychotic Agents; Body Temperature; Calcium; Cardiac Compl | 1971 |
Parasystole.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Carotid Sinus; Coronary Disea | 1968 |
Iatrogenic cardiovascular disease (an aspect of preventive cardiology).
Topics: Abnormalities, Drug-Induced; Analgesics; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antidepressi | 1968 |
Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease.
Topics: Ambulatory Care; Arrhythmias, Cardiac; Coronary Disease; Humans; Injections, Intramuscular; Phenytoi | 1972 |
Treatment of ventricular arrhythmias in ambulatory patients.
Topics: Ambulatory Care; Aneurysm; Coronary Disease; Death, Sudden; Electrocardiography; Humans; Pacemaker, | 1972 |
Rational use of antiarrhythmic drugs alone and in combination.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitalis Glycosides; Drug Therapy, | 1974 |
[Drug therapy of arrhythmia--its therapeutic and adverse effects].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Circulation; Blood Vessels; Cardiomyopa | 1968 |
7 trials available for procainamide and Coronary Disease
| Article | Year |
|---|---|
Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.
Topics: Acecainide; Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relationship, Drug; E | 1981 |
Prospective studies evaluating prophylactic ICD therapy for high risk patients with coronary artery disease.
Topics: Aged; Coronary Disease; Defibrillators, Implantable; Electrocardiography; Heart Arrest; Humans; Male | 1993 |
Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Coronary Disease; Delaye | 1996 |
[Effect of prajmalium bitartrate and procaine amide on ventricular extrasystoles (author's transl)].
Topics: Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiomyopathies; Coron | 1976 |
Myocardial contractility in patients with ischemic heart disease during long-term administration of quinidine and procainamide. Direct measurement of segmental shortening with radiopaque epicardial markers.
Topics: Blood Pressure; Cineradiography; Coronary Disease; Heart Rate; Heart Ventricles; Humans; Myocardial | 1979 |
Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Electrophysiology; Fe | 1985 |
[Procaine amide as a prophylactic drug against atrial fibrillation. A controlled study].
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Atrial Fibrillation; Coronary Disease; Electric Counters | 1969 |
100 other studies available for procainamide and Coronary Disease
| Article | Year |
|---|---|
Procaine amide therapy in auricular flutter with 1:1 A-V conduction.
Topics: Atrial Flutter; Coronary Disease; Heart Rate; Humans; Procainamide | 1954 |
Effect of pronestyl on experimental coronary occlusion in hypothermic dogs.
Topics: Animals; Coronary Disease; Coronary Occlusion; Dogs; Hypothermia; Procainamide | 1957 |
THE MANAGEMENT OF MEDICAL CARDIAC ARREST.
Topics: Aortic Valve Stenosis; Bicarbonates; Coronary Disease; Diuretics; Electrocardiography; Epinephrine; | 1963 |
[VENTRICULAR TACHYCARDIA].
Topics: Atrial Fibrillation; Blood Pressure Determination; Coronary Disease; Electrocardiography; Geriatrics | 1964 |
ATRIOVENTRICULAR BLOCK: A CLINICAL STUDY.
Topics: Africa; Africa, Southern; Atrioventricular Block; Coronary Disease; Geriatrics; Heart Block; Myocard | 1964 |
VENTRICULAR TACHYCARDIA: AN AWESOME ARRHYTHMIA.
Topics: Arrhythmias, Cardiac; Blood Pressure Determination; Coronary Disease; Digitalis; Digitalis Glycoside | 1964 |
PAROXYSMAL VENTRICULAR TACHYCARDIA.
Topics: Coronary Disease; Diagnosis; Digitalis Glycosides; Electrocardiography; Heart Failure; Hydrocortison | 1964 |
A CLINICAL TRIAL OF ANTAZOLINE IN THE TREATMENT OF ARRHYTHMIAS.
Topics: Antazoline; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; | 1964 |
ELECTRICAL CONVERSION OF VENTRICUALAR TACHYCARDIA.
Topics: Coronary Disease; Drug Therapy; Electric Countershock; Electrocardiography; Humans; Lidocaine; Proca | 1965 |
Electroshock therapy for cardiac arrhythmias: a follow-up study of 34 patients.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Digitalis Glycosides; Electric Coun | 1967 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease.
Topics: Acecainide; Adult; Aged; Coronary Disease; Creatinine; Female; Half-Life; Humans; Infusions, Parente | 1980 |
Evaluation of postextrasystolic T wave alterations in identification of patients with coronary artery disease or left ventricular dysfunction.
Topics: Adult; Aged; Cardiac Complexes, Premature; Coronary Disease; Digitalis Glycosides; Electrocardiograp | 1981 |
Effects of procainamide and N-acetylprocainamide on myocardial contractility in ischemic isolated rabbit hearts.
Topics: Acecainide; Animals; Coronary Disease; Disease Models, Animal; Epinephrine; Male; Myocardial Contrac | 1981 |
Evolving concepts of management of stable and potentially lethal arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; Dose-Response Relationship, Dr | 1982 |
Procainamide in the induction and perpetuation of ventricular tachycardia in man.
Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Chronic Disease; Coronary Disease; Dose-Response | 1982 |
Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation.
Topics: Acecainide; Administration, Oral; Adult; Aged; Coronary Disease; Delayed-Action Preparations; Female | 1983 |
[Detection and long-term treatment of ventricular extrasystole in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Female; Heart Ventricles; Humans; | 1983 |
Management of ventricular dysrhythmias in the prehospital and emergency department setting.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Coronary Disease; Electric Countersho | 1984 |
Verapamil in ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Dose-Response Relationship, D | 1984 |
Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathies; Catecholamines; Coronary Disease; Electrophys | 1983 |
The electrophysiological actions of lidocaine on ischemic ventricular muscle as compared with procainamide.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Guinea Pigs; Hydrogen-Ion Concen | 1983 |
[Kawasaki disease with coronary involvement].
Topics: Adrenal Cortex Hormones; Age Factors; Aneurysm; Child; Coronary Disease; Digitalis Glycosides; Human | 1983 |
Intropic effects of several antiarrhythmic drugs.
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Bunaftine; Coronary Disease; Disopyrami | 1983 |
Low-dose procainamide: low risk of complications with long-term use.
Topics: Adult; Aged; Coronary Disease; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pro | 1983 |
[Efficacy of pharmacological prevention after the first attack of ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Coronary Disease; Humans; Lidocaine; Procainamide; Quinidine; Tachycardia | 1982 |
Cellular electrophysiology in acute and healed experimental myocardial infarction.
Topics: Action Potentials; Acute Disease; Animals; Cats; Cell Survival; Coronary Disease; Death, Sudden; Ele | 1982 |
Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death.
Topics: Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Angiography; Coronary Artery Bypas | 1982 |
Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Disease Models, Animal; Dogs; Femal | 1982 |
Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
Topics: Acute Disease; Aged; Chronic Disease; Coronary Disease; Dose-Response Relationship, Drug; Electrocar | 1981 |
Usefulness of the systolic time intervals in cardiovascular clinical cardiology.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Digitalis Glycosides; Dose-Response Relationship, Drug; Fe | 1982 |
Ventricular tachyarrhythmias in regional myocardial hyperkalemia: efficacy of three antiarrhythmic agents.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction Syste | 1980 |
Procainamide delivery to ischemic canine myocardium following rapid intravenous administration.
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Procainamide; Time Factors | 1980 |
Modification of ventricular tachycardia by procainamide in patients with coronary artery disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Female; Heart Ventricles; Humans; Male; Middl | 1980 |
Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Electrop | 1994 |
Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Coronary Disease; Electrocardiography; | 1993 |
Myocardial uptake and pharmacodynamics of procainamide in patients with coronary heart disease and sustained ventricular tachyarrhythmias.
Topics: Aged; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; | 1993 |
Combined transesophageal left atrial pacing and antiarrhythmic therapy in the treatment of atrial flutter.
Topics: Ambulatory Care; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Fun | 1996 |
[Out patient prophylaxis of arrhythmias due to coronary insufficiency (author's transl)].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Humans; | 1976 |
Mechanisms contributing to dysrhythmias induced by ischemia and their therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease | 1978 |
Arrhythmia prophylaxis: Long-term suppressive medication.
Topics: Acute Disease; Aged; Alprenolol; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Diseas | 1975 |
Should premature ventricular beats be treated in the ambulatory patient? An antagonist's view.
Topics: Adult; Aged; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden; Electrocardiography; Fol | 1977 |
N-acetylprocainamide and ischemia-induced ventricular fibrillation in the dog.
Topics: Acecainide; Animals; Blood Pressure; Coronary Disease; Dogs; Electrocardiography; Female; Heart Rate | 1979 |
Preventing ventricular arrhythmias in ischemic heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Lidocaine; Nitroglyce | 1979 |
Characteristics of ventricular tachycardia in ambulatory patients.
Topics: Ambulatory Care; Cardiomyopathy, Hypertrophic; Coronary Disease; Digitalis Glycosides; Electrocardio | 1977 |
Relationship between regional myocardial procainamide concentration and regional myocardial blood flow during ischemia in the dog.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Heart; Heart Rate; Procainamide; Regional Blood Flo | 1978 |
Exacerbation of coronary occlusion induced ventricular arrhythmias by the vagolytic effect of procainamide.
Topics: Animals; Arrhythmias, Cardiac; Cats; Coronary Disease; Female; Heart Ventricles; Hemodynamics; Male; | 1978 |
Spontaneous heart rate, ventricular tachycardia, and the response to procainamide during acute ischemia.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Disease Models, Animal; Dogs; Heart; Heart Rate; Ma | 1977 |
Treatment of recurrent symptomatic ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Drug Evaluation; Female; He | 1976 |
The management of acute myocardial infarction.
Topics: Acute Disease; Arrhythmias, Cardiac; Catecholamines; Coronary Disease; Glycosides; Humans; Lidocaine | 1975 |
Effects of procainamide on the dispersion of recovery of excitability during coronary occlusion.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Heart Conduction System; Myocardial Contraction; Ne | 1976 |
Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Dogs; | 1990 |
Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
Topics: Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Ele | 1991 |
Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms.
Topics: Cardiac Pacing, Artificial; Coronary Disease; Drug Evaluation; Electrocardiography; Humans; Infusion | 1992 |
Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery disease.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Digoxin; Heart Arrest; Humans; Middle | 1990 |
Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrophysiology; Female; Heart; Humans; | 1990 |
Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Topics: Acecainide; Aged; Coronary Disease; Electrocardiography; Electrophysiology; Female; Heart Arrest; He | 1985 |
Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Electrophysiology; Female; Heart Ventricles; | 1987 |
Effects of long-term procainamide therapy on immunoglobulin synthesis.
Topics: Aged; Antibodies, Monoclonal; Antibody-Producing Cells; Coronary Disease; Female; Humans; Hypertensi | 1985 |
Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
Topics: Acyl Coenzyme A; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Disopyramide; Dogs; Fat | 1988 |
Strength-interval relation for ventricular functional refractoriness.
Topics: Adult; Aged; Coronary Disease; Electrocardiography; Electrophysiology; Female; Heart Conduction Syst | 1988 |
Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
Topics: Action Potentials; Adult; Aged; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Diseas | 1988 |
Cycle length-dependent effects on normal and abnormal intraventricular electrograms: effect of procainamide.
Topics: Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Humans; Procainamide | 1988 |
Simultaneous appearance of endocardial late potentials and ability to induce sustained ventricular tachycardia after procainamide administration.
Topics: Adult; Cardiac Pacing, Artificial; Coronary Artery Bypass; Coronary Disease; Electrocardiography; En | 1986 |
Immunohistochemical localization of procainamide in normal, ischemic, and necrotic canine myocardium during acute experimental myocardial infarction.
Topics: Animals; Coronary Disease; Dogs; Histocytochemistry; Immunochemistry; Myocardial Infarction; Myocard | 1987 |
Effect of myocardial ischemia and type I antiarrhythmic drug therapy on exercise QT intervals.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test; Heart Co | 1985 |
Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Humans; Male; Middle | 1986 |
Cellular electrophysiologic changes and "arrhythmias" during experimental ischemia and reperfusion in isolated cat ventricular myocardium.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Cats; Coronary Circulation; Coronary Dise | 1986 |
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disease; Drug Therapy, Com | 1985 |
Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antibody Formation; Arrhythmias, Cardiac; Coronary | 1970 |
Reversible procainamide-induced agranulocytosis twice in one patient.
Topics: Adenocarcinoma; Aged; Agranulocytosis; Coronary Disease; Female; Heart Neoplasms; Humans; Myocardial | 1971 |
EKG of the month. Sinus rhythm and premature ventricular beats.
Topics: Coronary Disease; Electrocardiography; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myoc | 1974 |
The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.
Topics: Anesthesia, General; Anesthesia, Inhalation; Arrhythmias, Cardiac; Atrial Flutter; Blood Pressure De | 1969 |
Procainamide-induced serologic changes in asymptomatic patients.
Topics: Aged; Antibodies, Antinuclear; Arrhythmias, Cardiac; Coronary Disease; Female; Heart Diseases; Human | 1969 |
Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.
Topics: Arrhythmias, Cardiac; Cardiomegaly; Coronary Disease; Diagnosis, Computer-Assisted; Electrocardiogra | 1973 |
[Rhythmic disorders due to digitalis overdose].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Arrhythmias, Cardiac; Coronary Disease; Digitalis Gl | 1972 |
Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
Topics: Acute Disease; Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; | 1974 |
The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Dogs; Ele | 1974 |
Bifascicular block: a clinical and electrophysiologic study.
Topics: Aged; Bundle-Branch Block; Cardiac Catheterization; Coronary Disease; Digitalis; Electrocardiography | 1973 |
Effect of procainamide on fibrillation threshold of normal and ischemic ventricles.
Topics: Animals; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Heart Ventricles; Procainami | 1974 |
Pathogenesis and prevention of sudden cardiac death.
Topics: Animals; Arteriosclerosis; Coronary Disease; Death, Sudden; Dogs; Heart; Humans; Lidocaine; Potassiu | 1974 |
Effect of procainamide and lidocaine on ventricular automaticity and reentry during acute coronary occlusion.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Heart Conduction System; Lidocaine; Procainam | 1974 |
Ectopic tachycardias with unusual retrograde conduction to the atria.
Topics: Adult; Aged; Chlorothiazide; Coronary Disease; Digitoxin; Electrocardiography; Ephedrine; Heart Bloc | 1966 |
Acute coronary insufficiency. Course and follow-up.
Topics: Adult; Aged; Angina Pectoris; Aspartate Aminotransferases; Coronary Disease; Creatine Kinase; Electr | 1972 |
Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol.
Topics: Animals; Coronary Disease; Dogs; Injections, Intra-Arterial; Injections, Intramuscular; Injections, | 1972 |
Procainamide prophylaxis in recurrent ventricular tachycardia due to ischemic heart disease.
Topics: Coronary Disease; Humans; Middle Aged; Procainamide; Tachycardia, Paroxysmal | 1965 |
The coronary care unit at Palmerston North Hospital.
Topics: Arrhythmias, Cardiac; Atropine; Coronary Disease; Death, Sudden; Electrocardiography; Female; Hospit | 1967 |
Long-term cardiac pacing. Experience of fixed-rate pacing with an endocardial electrode in 260 patients.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Arthritis, Rheumatoid; Coronary Disease; Diabetes Com | 1969 |
DC countershock for cardiac arrhythmias.
Topics: Adult; Atrial Fibrillation; Atrial Flutter; Atropa belladonna; Coronary Disease; Electric Countersho | 1966 |
Cardiac arrhythmias during electroshock therapy: significance, prevention, and treatment.
Topics: Acidosis, Respiratory; Aged; Arrhythmias, Cardiac; Blood Gas Analysis; Coronary Disease; Electrocard | 1970 |
Bretylium tosylate in the management of refractory ventricular fibrillation.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bretyl | 1971 |
Atrial pacing to control heart rate and rhythm in acute cardiac conditions.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Volume; Bradycardia; Cardiac Catheterization | 1971 |
Selected clinical features of paroxysmal tachycardia. A prospective study in 120 patients.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Cardiomyopathies; Child; Child, Preschool; Coronary Diseas | 1971 |
[Treatment of arrhythmias].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Diet, Sodium-Restricted; Humans; Hyp | 1967 |
A "link trainer" for the coronary care unit.
Topics: Arrhythmias, Cardiac; Atropine; Computers; Coronary Disease; Data Display; Digitalis Glycosides; Edu | 1968 |
[Therapy of the anginose symptom complex and arrhythmia with stenocardin].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Erythrityl Tetranitrate; Female; Humans; Male; | 1968 |
[Preventive effect of procainamide in digitalis-induced ventricular ectopic beats].
Topics: Aged; Coronary Disease; Digitalis Glycosides; Humans; Middle Aged; Procainamide; Ventricular Fibrill | 1969 |
Fever and chills as a reaction to procainamide hydrochloride therapy.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Female; Fever; Humans; Male; Middle Aged; Proca | 1965 |
[Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes].
Topics: Animals; Coronary Disease; Coronary Vessels; Dogs; Electrolytes; Isoniazid; Monoamine Oxidase Inhibi | 1965 |
Recurrent ventricular fibrillation treated by multiple countershocks.
Topics: Coronary Disease; Dextrans; Electric Countershock; Electrocardiography; Humans; Lidocaine; Male; Mid | 1966 |